Thymosin Alpha‑1 (TA1) is a powerful research-grade peptide used to boost immune response, reduce inflammation, and support recovery—widely studied across conditions like infections, cancer, and immune deficiency.

Why Researchers Choose TA1

• Enhances immune function – Supports T cells, dendritic cells, and antibody responses

• Reduces inflammation – Modulates cytokines, may help reduce sepsis and chronic inflammation 

• Supports vaccine & cancer research – Proven use in boosting vaccine efficacy and as adjunct in cancer treatment

• Simple lab format – 10 mg of ≥ 99 % purity, lyophilized peptide for study use 

Easy Science Explanation TA1 enhances the immune system by activating key cells (T cells, dendritic cells) and helping balance cytokines—making it valuable for studies in immunity, infection, inflammation, and tissue repair .

FAQs Q: How soon do effects appear? A: Immune-boosting effects often seen after a few doses; typical protocols are 1–2 mg twice weekly 

Q: Is TA1 safe? A: Generally well tolerated. Mild injection-site reactions, headaches, or fatigue are rare. TA1 is approved and used clinically in over 30 countries

Order Thymosin Alpha‑1 10 mg now—support your next immune, inflammation, or vaccine research with confidence.